loading page

Surgical excision methods for skin cancer involving the nail unit: a systematic review
  • +4
  • Claire Hardie,
  • Ryckie Wade,
  • Justin Wormald,
  • Brian Stafford,
  • Faye Elliott,
  • Julia Newton-Bishop,
  • Donald Dewar
Claire Hardie
University of Leeds Faculty of Medicine and Health

Corresponding Author:clairemhardie@gmail.com

Author Profile
Ryckie Wade
University of Leeds Faculty of Medicine and Health
Author Profile
Justin Wormald
Oxford University
Author Profile
Brian Stafford
World Health Organization
Author Profile
Faye Elliott
University of Leeds Faculty of Medicine and Health
Author Profile
Julia Newton-Bishop
University of Leeds Faculty of Medicine and Health
Author Profile
Donald Dewar
Leeds Teaching Hospitals NHS Trust
Author Profile

Abstract

Introduction Skin cancer affecting the nail unit is rare but is associated with morbidity, and melanoma has a high mortality rate. The principal treatment is surgical excision and methods can be classified into digit-sparing surgery or amputation. Digit-sparing surgery (wide excision or Mohs surgery) may be safe and effective for malignancies involving the nail unit in comparison to amputation if there is not bony invasion. The objective was to assess the efficacy and safety of different methods of surgical excision for skin cancer involving the nail unit. Methods Prospective comparative studies (randomised controlled, non-randomised controlled and prospective observational studies) of surgical excision for skin cancer of the nail unit in all participants were eligible for inclusion. We searched electronic databases, trials registers and conference abstracts. We checked the reference lists of included studies and related systematic reviews for further references to relevant studies, and we contacted experts to enquire if they were aware of any additional relevant trials. We used standard methodological procedures expected by Cochrane. The primary outcomes were overall survival, disease free survival and adverse events/outcomes at 30 days. The secondary outcomes were quality of life outcomes. We planned to use GRADE to assess the quality of the evidence for each outcome. Results We did not identify any studies that met the inclusion criteria for this review. We have been unable to assess our outcomes of overall survival, disease free survival, adverse events/effects and quality of life. Conclusions As we have not identified any studies for inclusion, we are unable to assess the efficacy and safety of different methods of surgical excision for skin cancer involving the nail unit. Prospective research, ideally in the form of a randomised trial, is required in this field. Registration Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD014590.
02 Jun 2023Submitted to Cochrane Evidence Synthesis and Methods
05 Jun 2023Submission Checks Completed
05 Jun 2023Assigned to Editor
28 Jun 2023Reviewer(s) Assigned
21 Aug 2023Review(s) Completed, Editorial Evaluation Pending
21 Aug 2023Editorial Decision: Revise Minor
31 Aug 20231st Revision Received
01 Sep 2023Submission Checks Completed
01 Sep 2023Assigned to Editor
01 Sep 2023Review(s) Completed, Editorial Evaluation Pending
15 Sep 2023Editorial Decision: Revise Minor
23 Sep 20232nd Revision Received
26 Sep 2023Submission Checks Completed
26 Sep 2023Assigned to Editor
26 Sep 2023Review(s) Completed, Editorial Evaluation Pending
03 Oct 2023Editorial Decision: Accept